| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |